热景生物
(688068)
| 流通市值：155.47亿 | | | 总市值：155.47亿 |
| 流通股本：9270.79万 | | | 总股本：9270.79万 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 120,554,344.28 | 183,921,969.46 | 179,150,227.74 | 270,149,505.21 |
| 交易性金融资产 | 669,321,261.16 | 398,694,648.58 | 558,551,397.45 | 201,505,264.51 |
| 应收票据及应收账款 | 131,423,918.53 | 122,052,754.94 | 117,695,605.45 | 92,477,262.84 |
| 其中：应收票据 | 404,322 | 19,630,902.44 | 3,873,810.53 | 600,000 |
| 应收账款 | 131,019,596.53 | 102,421,852.5 | 113,821,794.92 | 91,877,262.84 |
| 应收款项融资 | - | 574,070.02 | - | 16,200 |
| 预付款项 | 22,033,225.96 | 20,484,977.12 | 30,639,387.13 | 17,888,964.11 |
| 其他应收款合计 | 3,199,259.52 | 3,057,236.97 | 3,342,837.78 | 4,121,543.9 |
| 存货 | 77,907,192.56 | 79,680,675.8 | 80,360,959.86 | 83,454,876.76 |
| 一年内到期的非流动资产 | 303,259,123.29 | 518,186,027.38 | 483,867,232.88 | 601,140,890.41 |
| 其他流动资产 | 11,118,978.61 | 10,791,689.69 | 16,186,636.87 | 21,668,802.49 |
| 流动资产合计 | 1,338,817,303.91 | 1,337,444,049.96 | 1,469,794,285.16 | 1,292,423,310.23 |
| 非流动资产: | | | | |
| 长期股权投资 | 406,627,292.94 | 422,520,025.09 | 311,815,102.03 | 315,816,411.11 |
| 其他权益工具投资 | 135,009,224.19 | 135,009,224.19 | 131,615,414.24 | 131,615,414.24 |
| 其他非流动金融资产 | 185,342,931.51 | 184,216,246.58 | 180,571,589.04 | 378,605,753.43 |
| 投资性房地产 | 23,382,513.51 | 23,508,506.04 | 23,670,647.47 | 23,760,491.1 |
| 固定资产 | 1,011,034,428.17 | 1,028,052,928.04 | 1,041,084,532.23 | 1,067,938,828.35 |
| 在建工程 | 6,075,022.69 | 5,673,304.95 | 5,623,800 | 5,623,800 |
| 使用权资产 | 267,611.67 | 185,615.58 | 223,470.3 | 227,357.51 |
| 无形资产 | 49,484,346.48 | 50,212,034.71 | 51,165,611.93 | 52,124,342.73 |
| 长期待摊费用 | 20,599,870.3 | 22,258,979.83 | 24,061,397.78 | 25,549,061.03 |
| 递延所得税资产 | 28,690,544.91 | 33,158,375.7 | 27,134,354.28 | 26,636,756.11 |
| 其他非流动资产 | 2,427,925.46 | 2,908,841.9 | 5,040,639.01 | 5,540,100.16 |
| 非流动资产平衡项目 | -0.01 | 0 | 0 | 0 |
| 非流动资产合计 | 1,868,941,711.82 | 1,907,704,082.61 | 1,802,006,558.31 | 2,033,438,315.77 |
| 资产总计 | 3,207,759,015.73 | 3,245,148,132.57 | 3,271,800,843.47 | 3,325,861,626 |
| 流动负债: | | | | |
| 短期借款 | 50,000,000 | 50,031,250 | 50,000,000 | - |
| 应付票据及应付账款 | 140,764,905.16 | 142,665,238.25 | 139,830,804.73 | 139,653,917.15 |
| 其中：应付票据 | 9,600,000 | 19,300,000 | 9,700,000 | - |
| 应付账款 | 131,164,905.16 | 123,365,238.25 | 130,130,804.73 | 139,653,917.15 |
| 合同负债 | 14,510,736.55 | 13,291,406.75 | 13,954,620.26 | 16,703,841.11 |
| 应付职工薪酬 | 16,279,547.91 | 16,029,165.28 | 15,665,780.79 | 20,364,491.39 |
| 应交税费 | 9,893,282.53 | 5,258,283.54 | 6,285,476.48 | 5,872,667.93 |
| 其他应付款合计 | 31,036,107.6 | 48,667,916.71 | 46,127,504.45 | 52,073,992.99 |
| 一年内到期的非流动负债 | 75,500.4 | 79,184.48 | 113,504.93 | 115,479.33 |
| 其他流动负债 | 1,761,728.23 | 21,079,223.32 | 1,495,861.47 | 1,109,515.82 |
| 流动负债合计 | 264,321,808.38 | 297,101,668.33 | 273,473,553.11 | 235,893,905.72 |
| 非流动负债: | | | | |
| 租赁负债 | 38,786.97 | 104,646.83 | 118,936.07 | 121,004.94 |
| 递延收益 | 13,885,566.69 | 13,621,936.29 | 16,073,970.69 | 15,751,170.69 |
| 递延所得税负债 | - | 446.07 | - | - |
| 非流动负债合计 | 13,924,353.66 | 13,727,029.19 | 16,192,906.76 | 15,872,175.63 |
| 负债合计 | 278,246,162.04 | 310,828,697.52 | 289,666,459.87 | 251,766,081.35 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 92,707,940 | 92,707,940 | 92,474,692 | 92,474,692 |
| 资本公积 | 336,945,828.66 | 335,056,033.84 | 325,128,640.39 | 321,410,553.55 |
| 减:库存股 | 188,577,808.98 | 205,323,172.38 | 205,323,172.38 | 133,893,256.85 |
| 其他综合收益 | 15,061,357.46 | 13,602,172.13 | 10,272,690.93 | 9,958,414.23 |
| 盈余公积 | 47,818,114.4 | 47,818,114.4 | 47,818,114.4 | 47,818,114.4 |
| 未分配利润 | 2,628,798,757.93 | 2,653,760,405.84 | 2,713,750,005.9 | 2,737,758,221.52 |
| 归属于母公司股东权益合计 | 2,932,754,189.47 | 2,937,621,493.83 | 2,984,120,971.24 | 3,075,526,738.85 |
| 少数股东权益 | -3,241,335.78 | -3,302,058.78 | -1,986,587.64 | -1,431,194.2 |
| 股东权益合计 | 2,929,512,853.69 | 2,934,319,435.05 | 2,982,134,383.6 | 3,074,095,544.65 |
| 负债和股东权益合计 | 3,207,759,015.73 | 3,245,148,132.57 | 3,271,800,843.47 | 3,325,861,626 |
| 公告日期 | 2025-10-24 | 2025-08-30 | 2025-04-30 | 2025-04-30 |
| 审计意见(境内) | | | | 标准无保留意见 |